Work

P48.14 RESILIENT Part 2: A phase 3 Study of Liposomal Irinotecan in Patients with Small-Cell Lung Cancer in the Second-Line Setting

Year: 2021

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2021.01.884

Authors: L. Paz-Ares, D.R. Spigel, Y. Chen, M. Jove, O. Juan-Vidal, P. Rich, T. Hayes, V. Gutiérrez Calderón, R.B. Caro, A. Navarro Mendivil, A. Dowlati, B. Zhang, Y. Moore, T. Wang, J. Kokhreidze, S. Ponce, P. Bunn

Institutions: Hospital Universitario 12 De Octubre, Sarah Cannon, Institut Català d'Oncologia, Hospital Universitari i Politècnic La Fe, Cancer Treatment Centers of America, Hospital Regional Universitario de Málaga, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío, Vall d'Hebron Hospital Universitari, Case Western Reserve University, Ipsen (United States)

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3136815915

Cites:

Cited by:

Related to: 10